Lorazepam and Daydreaming - a phase IV clinical study of FDA data

Summary:

Daydreaming is reported as a side effect among people who take Lorazepam (lorazepam), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Sertraline, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Daydreaming when taking Lorazepam. It is created by eHealthMe based on reports of 161,687 people who have side effects when taking Lorazepam from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,626 Lorazepam users. Check the latest studies of Lorazepam.

What is Daydreaming?

Daydreaming is found to be associated with 247 drugs and 642 conditions by eHealthMe. Check the latest studies of Daydreaming.

On Aug, 15, 2025

161,687 people reported to have side effects when taking Lorazepam.
Among them, 31 people (0.02%) have Daydreaming.

Among these 31 people:

How long have people been on Lorazepam when they have Daydreaming? *

What is the gender of people who have Daydreaming when taking Lorazepam? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Daydreaming when taking Lorazepam? *

What are other drugs people take besides Lorazepam? *

What are other side effects people have besides Daydreaming? *

Drowsiness: 13 people, 41.94%
Memory Loss: 11 people, 35.48%
Feeling Abnormal: 9 people, 29.03%
Hallucinations (sensations that appear real but are created by your mind): 8 people, 25.81%
Gait Disturbance: 7 people, 22.58%
On And Off Phenomenon: 6 people, 19.35%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 6 people, 19.35%
Fatigue (feeling of tiredness): 6 people, 19.35%
Speech Disorder: 6 people, 19.35%
Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs): 6 people, 19.35%

What are the existing conditions these people have? *

Parkinson's Disease: 7 people, 22.58%
Sleep Disorder: 2 people, 6.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.45%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 3.23%
High Blood Cholesterol: 1 person, 3.23%
Bipolar Disorder (mood disorder): 1 person, 3.23%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.23%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.23%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 3.23%
Depression: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and have Daydreaming?

- Check whether Daydreaming is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lorazepam:

Lorazepam (165,626 reports)

Daydreaming treatments and more:

Daydreaming (1,811 reports)

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Daydreaming:

Daydreaming (247 drugs)

Browse all the conditions that are associated with Daydreaming:

Daydreaming (642 conditions)

Drugs similar to Lorazepam and Daydreaming :

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Lorazepam) and Lorazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.